Ubiquitin- and ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Biology Reports

• Publication date

  2012-11-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11033-012-2261-0PMID 23187732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The transcriptional activity of co‐activator AIB1 is regulated by the SUMO E3 Ligase PIAS1

  2012cited by this paper
• Proteasome inhibitors: an expanding army attacking a unique target.

  2012cited by this paper
• Emerging regulatory mechanisms in ubiquitin-dependent cell cycle control

  2012cited by this paper
• HECT and RING finger families of E3 ubiquitin ligases at a glance

  2012cited by this paper
• SUMO playing tag with ubiquitin.

  2012cited by this paper
• The ubiquitin–proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer

  2012cited by this paper
• ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells

  2012cited by this paper
• Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.

  2012cited by this paper
• The diverse and complex roles of NF-κB subunits in cancer

  2012cited by this paper
• Evolutionary pathways in BRCA1-associated breast tumors.

  2012cited by this paper
• BRCA1 tumor suppressor network: focusing on its tail

  2012cited by this paper
• Emerging roles for Lys11-linked polyubiquitin in cellular regulation.

  2011cited by this paper
• Constructing and decoding unconventional ubiquitin chains

  2011cited by this paper
• K11-linked ubiquitin chains as novel regulators of cell division.

  2011cited by this paper
• Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins

  2011cited by this paper
• Ubiquitin, ubiquitination and the ubiquitin-proteasome system in cancer

  2011cited by this paper
• E1-E2 Interactions in Ubiquitin and Nedd8 Ligation Pathways*

  2011cited by this paper
• Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer

  2011cited by this paper
• Cracking the estrogen receptor's posttranslational code in breast tumors.

  2011cited by this paper
• Sumoylation regulates nuclear localization of repressor DREAM.

  2011cited by this paper
• Substrate-specific regulation of ubiquitination by the anaphase-promoting complex

  2011cited by this paper
• The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery.

  2011cited by this paper
• Rad6B acts downstream of Wnt signaling to stabilize β-catenin: Implications for a novel Wnt/β-catenin target

  2011cited by this paper
• Ubiquitin networks in cancer.

  2011cited by this paper
• RAD6 Regulates the Dosage of p53 by a Combination of Transcriptional and Posttranscriptional Mechanisms

  2011cited by this paper
• NF-κB, stem cells and breast cancer: the links get stronger

  2011cited by this paper
• Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus*

  2011cited by this paper
• Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells

  2011cited by this paper
• E2s: structurally economical and functionally replete.

  2011cited by this paper
• Expression of the novel human gene, UBE2Q1, in breast tumors

  2011cited by this paper
• Interferon-Stimulated Gene 15 and the Protein ISGylation System

  2011cited by this paper
• Over-accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9.

  2011cited by this paper
• An allosteric inhibitor of the human Cdc34 ubiquitin-conjugating enzyme.

  2011cited by this paper
• Harnessing synthetic lethal interactions in anticancer drug discovery

  2011cited by this paper
• Rad 6 B acts downstream of Wnt signaling to stabilize b-catenin : Implications for a novel Wnt / b-catenin target

  2011cited by this paper
• The docking protein p130Cas regulates cell sensitivity to proteasome inhibition

  2011cited by this paper
• SUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor

  2010cited by this paper
• Ser120 of Ubc2/Rad6 Regulates Ubiquitin-dependent N-end Rule Targeting by E3α/Ubr1*

  2010cited by this paper
• Small-molecule inhibitors of MDM2 as new anticancer therapeutics.

  2010cited by this paper
• SLUG-induced Elevation of D1 Cyclin in Breast Cancer Cells through the Inhibition of Its Ubiquitination*

  2010cited by this paper
• NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways

  2010cited by this paper
• Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response

  2010influential reference
• RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

  2010cited by this paper
• Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer

  2010cited by this paper
• Overexpression of the novel human gene, UBE2Q2, in breast cancer.

  2010cited by this paper
• BRCA1 regulates acetylation and ubiquitination of estrogen receptor-alpha.

  2010cited by this paper
• Long-range transcriptional control of progesterone receptor gene expression.

  2010cited by this paper
• Bortezomib-induced "BRCAness" sensitizes multiple myeloma cells to PARP inhibitors.

  2010cited by this paper
• Systematic in vivo RNAi analysis identifies IAPs as NEDD8-E3 ligases.

  2010influential reference
• Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells

  2010cited by this paper
• Protein–protein interactions involving IKKγ (NEMO) that promote the activation of NF‐κB

  2010cited by this paper
• Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation

  2010cited by this paper
• Traffic control for BRCA1.

  2010cited by this paper
• Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts

  2010cited by this paper
• The regulation of the p53-mediated stress response by MDM2 and MDM4.

  2010cited by this paper
• The family of ubiquitin‐conjugating enzymes (E2s): deciding between life and death of proteins

  2010cited by this paper
• BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer

  2010cited by this paper
• Ki67 in breast cancer: prognostic and predictive potential.

  2010cited by this paper
• Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancer

  2010cited by this paper
• Personalized treatment of early-stage breast cancer: present concepts and future directions.

  2010cited by this paper
• Clinicopathological relevance of UbcH10 in breast cancer

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• Validation of UBE2C protein as a prognostic marker in node-positive breast cancer

  2009cited by this paper
• What Was the Set of Ubiquitin and Ubiquitin-Like Conjugating Enzymes in the Eukaryote Common Ancestor?

  2009cited by this paper
• Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7

  2009cited by this paper
• Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner

  2009cited by this paper
• Adenosine Signaling Mediates SUMO-1 Modification of IκBα during Hypoxia and Reoxygenation*

  2009cited by this paper
• The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

  2009cited by this paper
• A novel mechanism whereby BRCA1/1a/1b fine tunes the dynamic complex interplay between SUMO-dependent/independent activities of Ubc9 on E2-induced ERalpha activation/repression and degradation in breast cancer cells.

  2009cited by this paper
• Proteasome inhibition represses ERα gene expression in ER+ cells- a new link between proteasome activity and estrogen signaling in breast cancer

  2009cited by this paper
• Mechanism of BRCA1-mediated inhibition of progesterone receptor transcriptional activity.

  2009cited by this paper
• Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells.

  2009cited by this paper
• Origin and function of ubiquitin-like proteins

  2009influential reference
• Analysis of activator-binding sites on the APC/C supports a cooperative substrate-binding mechanism.

  2009cited by this paper
• Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

  2009cited by this paper
• Principles of ubiquitin and SUMO modifications in DNA repair

  2009cited by this paper
• Apollon gene silencing induces apoptosis in breast cancer cells through p53 stabilisation and caspase-3 activation

  2009cited by this paper
• The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

  2008cited by this paper
• Revealing targeted therapy for human cancer by gene module maps.

  2008cited by this paper
• Rad6B is a positive regulator of beta-catenin stabilization.

  2008cited by this paper
• Modulation of PLAGL2 transactivation activity by Ubc9 co-activation not SUMOylation.

  2008cited by this paper
• Final stages of cytokinesis and midbody ring formation are controlled by BRUCE.

  2008cited by this paper
• Targeting the UPS as therapy in multiple myeloma

  2008cited by this paper
• Activating the ubiquitin family: UBA6 challenges the field.

  2008cited by this paper
• Polyubiquitin chains: functions, structures, and mechanisms

  2008cited by this paper
• Ubiquitin‐conjugating Enzymes

  2008cited by this paper
• ISG15 as a novel tumor biomarker for drug sensitivity

  2008cited by this paper
• SUMO and estrogen receptors in breast cancer

  2007cited by this paper
• Basis for a ubiquitin-like protein thioester switch toggling E1–E2 affinity

  2007cited by this paper
• RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.

  2007cited by this paper
• SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy

  2007cited by this paper
• Sensitization against anticancer drugs by transfection with UBE2I variant gene into ras-NIH3H3 mouse fibroblasts.

  2007cited by this paper
• Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

  2007cited by this paper
• Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway*

  2007cited by this paper
• The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition.

  2007cited by this paper
• UbcH10 is overexpressed in malignant breast carcinomas.

  2007cited by this paper
• Ubiquitin-Binding Protein RAP80 Mediates BRCA1-Dependent DNA Damage Response

  2007cited by this paper
• Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

  2007cited by this paper
• Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

  2007cited by this paper
• Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.

  2006cited by this paper

• Genetic variants associated with gout identified through a genome-wide study in the UK biobank (N = 150 542)

  2025cites this paper
• A Multiomics, Molecular Atlas of Breast Cancer Survivors

  2024cites this paper
• KHSRP has oncogenic functions and regulates the expression and alternative splicing of DNA repair genes in breast cancer MDA-MB-231 cells

  2024cites this paper
• Integrated Omics Approach: Revealing the Mechanism of Auxenochlorella pyrenoidosa Protein Extract Replacing Fetal Bovine Serum for Fish Muscle Cell Culture.

  2024cites this paper
• Analysis of the interaction of UBE2Q1 with B4GALT1 and P53: Experimental and molecular modeling study.

  2023cites this paper
• Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.

  2021cites this paper
• The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy

  2021cites this paper
• Expression profiles and potential functions of long noncoding RNAs and mRNAs in autoimmune pulmonary alveolar proteinosis patients

  2021cites this paper
• Long non-coding RNA HCG18 promotes malignant phenotypes of breast cancer (BC) cells by HCG18/miR-103a-3p/UBE2O/mTORC1/HIF-1α positive feedback loop

  2021cites this paper
• Mutations of p53 associated with pancreatic cancer and therapeutic implications

  2021cites this paper
• Comprehensive analysis of differentially expressed genes reveals the promotive effects of UBE2T on colorectal cancer cell proliferation

  2021cites this paper
• TF–RBP–AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers

  2021cites this paper
• MYO10 drives genomic instability and inflammation in cancer

  2021cites this paper
• Small Molecules Targeting Programmed Cell Death in Breast Cancer Cells

  2021cites this paper
• The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials

  2021cites this paper
• Long Noncoding RNA HCG18 Promotes Malignant Phenotypes of Breast Cancer Cells via the HCG18/miR-103a-3p/UBE2O/mTORC1/HIF-1α–Positive Feedback Loop

  2021cites this paper
• The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer

  2020cites this paper
• UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma

  2019cites this paper
• Krüppel-like factors in breast cancer: Function, regulation and clinical relevance.

  2019cites this paper
• UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma

  2019cites this paper
• PNO1 promotes cell proliferation in prostate cancer

  2019cites this paper
• Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer

  2018cites this paper
• Digital gene expression profiling analysis and its application in the identification of genes associated with improved response to neoadjuvant chemotherapy in breast cancer

  2018cites this paper
• Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

  2016cites this paper
• Induction of cell proliferation, clonogenicity and cell accumulation in S phase as a consequence of human UBE2Q1 overexpression.

  2016cites this paper
• Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3

  2016cites this paper
• Mechanism and disease association of E 2-conjugating enzymes : lessons from UBE 2 T and UBE 2 L 3

  2016cites this paper
• Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications

  2015cites this paper
• E2 superfamily of ubiquitin-conjugating enzymes: constitutively active or activated through phosphorylation in the catalytic cleft

  2015cites this paper
• UBE2Q1 in a Human Breast Carcinoma Cell Line: Overexpression and Interaction with p53.

  2015cites this paper
• Ubiquitination involved enzymes and cancer

  2014cites this paper
• Imagerie multi-spectrale par résonance des plasmons de surface : développement et applications

  2014cites this paper
• Identification of Sumoylation Inhibitors Targeting a Predicted Pocket in Ubc9

  2014cites this paper